Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease.
作者信息
Radojcic Vedran, Pletneva Maria, Lee Catherine J, Ivcevic Sanja, Sarantopoulos Stefanie, Couriel Daniel
机构信息
Department of Internal Medicine, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
出版信息
Br J Haematol. 2021 Oct;195(2):e120-e122. doi: 10.1111/bjh.17657. Epub 2021 Jun 17.
Abstract
摘要
相似文献
1
Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease.
Br J Haematol. 2021 Oct;195(2):e120-e122. doi: 10.1111/bjh.17657. Epub 2021 Jun 17.
2
Hedgehog-like moustache trichomegaly during treatment with vismodegib.
J Eur Acad Dermatol Venereol. 2020 Jan;34(1):e11-e13. doi: 10.1111/jdv.15842. Epub 2019 Sep 4.
3
Vismodegib (Erivedge) for basal cell carcinoma.
Med Lett Drugs Ther. 2012 Jul 9;54(1394):53-4.
4
Vismodegib: a guide to its use in locally advanced or metastatic basal cell carcinoma.
Am J Clin Dermatol. 2013 Feb;14(1):61-4. doi: 10.1007/s40257-012-0004-6.
5
Vismodegib: a promising drug in the treatment of basal cell carcinomas.
Future Oncol. 2012 Aug;8(8):915-28. doi: 10.2217/fon.12.82.
6
Harnessing hedgehog for the treatment of basal cell carcinoma.
JAMA Dermatol. 2013 May;149(5):607-8. doi: 10.1001/jamadermatol.2013.448.
7
Hedgehog hopes lifted by approval... and stung by failure.
Nat Biotechnol. 2012 Mar 7;30(3):203. doi: 10.1038/nbt0312-203.
8
Four-year experience with vismodegib hedgehog inhibitor therapy.
J Am Acad Dermatol. 2016 Jun;74(6):1264-5. doi: 10.1016/j.jaad.2015.12.035.
9
Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA.
Ann Oncol. 2016 Jul;27(7):1349-50. doi: 10.1093/annonc/mdw138. Epub 2016 Mar 21.
10
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families.
Clin Exp Dermatol. 2020 Dec;45(8):1044-1046. doi: 10.1111/ced.14287. Epub 2020 Aug 26.
引用本文的文献
1
Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease Exhibits Activation of T Helper 1 and OX40 Cytokines.
J Invest Dermatol. 2024 Mar;144(3):563-572.e9. doi: 10.1016/j.jid.2023.08.026. Epub 2023 Sep 23.
本文引用的文献
1
Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
J Clin Invest. 2019 Dec 2;129(12):5151-5162. doi: 10.1172/JCI128644.
2
Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulation.
J Clin Invest. 2019 Jul 2;129(8):3153-3170. doi: 10.1172/JCI125170.
3
Phase 1 study of the Hedgehog pathway inhibitor sonidegib for steroid-refractory chronic graft-versus-host disease.
Blood Adv. 2017 Oct 5;1(22):1919-1922. doi: 10.1182/bloodadvances.2017011239. eCollection 2017 Oct 10.
4
Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant. 2016 Mar;22(3):449-55. doi: 10.1016/j.bbmt.2015.10.018. Epub 2015 Nov 2.
5
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.
Biol Blood Marrow Transplant. 2015 Jun;21(6):984-99. doi: 10.1016/j.bbmt.2015.02.025. Epub 2015 Mar 19.
6
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant. 2015 Feb;21(2):266-74. doi: 10.1016/j.bbmt.2014.10.021. Epub 2014 Oct 30.
7
Tissue-derived hedgehog proteins modulate Th differentiation and disease.
J Immunol. 2013 Mar 15;190(6):2641-9. doi: 10.4049/jimmunol.1202541. Epub 2013 Feb 13.
8
Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis.
Arch Dermatol Res. 2013 Jan;305(1):1-8. doi: 10.1007/s00403-012-1304-7. Epub 2012 Dec 4.
9
Macrophage-derived Hedgehog ligands promotes fibrogenic and angiogenic responses in human schistosomiasis mansoni.
Liver Int. 2013 Jan;33(1):149-61. doi: 10.1111/liv.12016. Epub 2012 Nov 1.
10
Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease.
Blood. 2012 Oct 4;120(14):2909-17. doi: 10.1182/blood-2012-01-403428. Epub 2012 Aug 22.
Zotero 插件